X0609 4 2026-08-11 0001658678 BioStem Technologies, Inc. BSEM 0002147189 POE BRANDON false C/O BIOSTEM TECHNOLOGIES, INC. 2836 CENTER PORT CIRCLE POMPANO BEACH FL 33064 false true false false Chief Financial Officer false Common Stock 2026-08-11 4 M false 10634 0.00 A 56368 D Stock Options (Right to Buy) 6.48 2035-08-19 Common Stock 38814 38814 D Stock Options (Right to Buy) 5.50 2036-02-11 Common Stock 117401 117401 D Restricted Stock Units Common Stock 8469 8469 D Restricted Stock Units 2026-08-11 4 M false 10634 0.00 D Common Stock 10634 21591 D Restricted Stock Units Common Stock 96909 96909 D These options vest according to the following schedule: 33% vested on August 11, 2026, with the remaining options vesting in equal quarterly installments over the subsequent two year period. These options vest according to the following schedule: 33% will vest on February 11, 2027, the one year anniversary of the grant date, with the remaining options vesting in equal quarterly installments over the subsequent two year period. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. These restricted stock units vest in equal quarterly installments over three years from the grant date (September 15, 2024). These restricted stock units vest according to the following schedule: 33% vested on August 11, 2026, with the remaining units vesting in equal quarterly installments over the subsequent two year period. Due to an administrative error, the vesting of the restricted stock units was not timely reported on a Form 4 within two business days of the applicable transaction date. These restricted stock units vest according to the following schedule: 33% will vest on February 11, 2027, the one year anniversary of the grant date, with the remaining units vesting in equal quarterly installments over the subsequent two year period. Exhibit 24 - Power of Attorney /s/ Katherine Gorrell, as Attorney-in-Fact 2026-08-20